| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | NEUTRAL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.09▼ | 1.09▼ | 1.09▼ | 1.06▲ | 1.02▲ |
| MA10 | 1.09▼ | 1.10▼ | 1.10▼ | 1.00▲ | 1.49▼ |
| MA20 | 1.10▼ | 1.09▼ | 1.07▲ | 1.11▼ | 1.79▼ |
| MA50 | 1.08▲ | 1.00▲ | 1.00▲ | 1.62▼ | 2.32▼ |
| MA100 | 1.01▲ | 1.09▼ | 1.25▼ | 1.88▼ | 9.85▼ |
| MA200 | 1.17▼ | 1.54▼ | 1.64▼ | 2.19▼ | 39.35▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | -0.005▼ | 0.000▲ | 0.042▲ | -0.008▼ |
| RSI | 49.390▼ | 53.842▲ | 54.650▲ | 38.536▼ | 32.420▼ |
| STOCH | 32.900 | 40.188 | 43.434 | 79.104 | 10.603▼ |
| WILL %R | -81.818▼ | -81.818▼ | -37.500 | -26.667 | -86.944▼ |
| CCI | -30.523 | -67.694 | -54.124 | 112.777▲ | -92.478 |
| ▼ GAP | $ALZN Open Gap Down %2 | Set Alert |
|
Saturday, March 21, 2026 09:23 AM
Detailed price information for Alzamend Neuro Inc (ALZN-Q) from The Globe and Mail including charting and trades.
|
|
Monday, March 16, 2026 05:00 AM
ATLANTA, March 16, 2026 /PRNewswire/ -- Alzamend Neuro, Inc. (Nasdaq: ALZN) ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 21/04/26 | 1.08 | 1.13 | 1.0615 | 1.07 | 46,458 |
| 20/04/26 | 1.08 | 1.13 | 1.0576 | 1.11 | 22,058 |
| 17/04/26 | 1.03 | 1.15 | 1.00 | 1.12 | 166,786 |
| 16/04/26 | 1.00 | 1.01 | 0.9701 | 1.00 | 47,265 |
| 15/04/26 | 1.06 | 1.06 | 0.99 | 1.02 | 50,697 |
| 14/04/26 | 0.8804 | 1.07 | 0.861 | 1.04 | 365,170 |
| 13/04/26 | 0.85 | 0.90 | 0.85 | 0.899 | 57,533 |
| 10/04/26 | 0.915 | 0.93 | 0.85 | 0.8575 | 63,741 |
| 09/04/26 | 0.93 | 0.9699 | 0.90 | 0.9025 | 49,333 |
| 08/04/26 | 0.942 | 1.05 | 0.8901 | 0.9312 | 61,203 |
|
|
||||
|
|
||||
|
|